{"entity":{"type":"insider","cik":"0001861790","url":"/insider/0001861790","json_url":"/insider/0001861790.json","name":"Monahan Joseph","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":11,"first":"2021-06-02","last":"2023-10-25","span_basis":"filed_date"},"name_variants":[{"name":"Monahan Joseph","source":"filing","n_filings":11,"first_seen":"2021-06-02","last_seen":"2023-10-25"}],"transactions":[{"id":7899779,"accession":"0001209191-23-053558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-053558","line_url":"/filing/0001209191-23-053558#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001861790","owner_name":"Monahan Joseph","owner_display_name":"Monahan Joseph","owner_url":"/insider/0001861790","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":5.0767,"price_display":"5.08","price_state":"stated","total_value":30460.2,"total_display":"30,460.20","total_whole":"30,460","shares_owned_after":129724.0,"shares_owned_after_display":"129,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-23","filed_date":"2023-10-25","scope":"insider"},{"id":7923164,"accession":"0001209191-23-046905","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-046905","line_url":"/filing/0001209191-23-046905#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001861790","owner_name":"Monahan Joseph","owner_display_name":"Monahan Joseph","owner_url":"/insider/0001861790","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":7.3158,"price_display":"7.32","price_state":"stated","total_value":43894.8,"total_display":"43,894.80","total_whole":"43,895","shares_owned_after":135724.0,"shares_owned_after_display":"135,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-22","scope":"insider"},{"id":8724018,"accession":"0001209191-23-039070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-039070","line_url":"/filing/0001209191-23-039070#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001861790","owner_name":"Monahan Joseph","owner_display_name":"Monahan Joseph","owner_url":"/insider/0001861790","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":10.2771,"price_display":"10.28","price_state":"stated","total_value":61662.6,"total_display":"61,662.60","total_whole":"61,663","shares_owned_after":141724.0,"shares_owned_after_display":"141,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-22","scope":"insider"},{"id":8744196,"accession":"0001209191-23-016065","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-016065","line_url":"/filing/0001209191-23-016065#line-6","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001861790","owner_name":"Monahan Joseph","owner_display_name":"Monahan Joseph","owner_url":"/insider/0001861790","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16037.0,"shares_display":"16,037","price_per_share":12.6342,"price_display":"12.63","price_state":"stated","total_value":202614.6654,"total_display":"202,614.67","total_whole":"202,615","shares_owned_after":147724.0,"shares_owned_after_display":"147,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-03","scope":"insider"},{"id":8744194,"accession":"0001209191-23-016065","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-016065","line_url":"/filing/0001209191-23-016065#line-5","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001861790","owner_name":"Monahan Joseph","owner_display_name":"Monahan Joseph","owner_url":"/insider/0001861790","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14800.0,"shares_display":"14,800","price_per_share":12.3665,"price_display":"12.37","price_state":"stated","total_value":183024.2,"total_display":"183,024.20","total_whole":"183,024","shares_owned_after":151261.0,"shares_owned_after_display":"151,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-03","scope":"insider"},{"id":8543363,"accession":"0001209191-23-010658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-010658","line_url":"/filing/0001209191-23-010658#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001861790","owner_name":"Monahan Joseph","owner_display_name":"Monahan Joseph","owner_url":"/insider/0001861790","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.0621,"price_display":"13.06","price_state":"stated","total_value":65310.5,"total_display":"65,310.50","total_whole":"65,311","shares_owned_after":91386.0,"shares_owned_after_display":"91,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-15","filed_date":"2023-02-17","scope":"insider"},{"id":6701203,"accession":"0001209191-22-061695","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-061695","line_url":"/filing/0001209191-22-061695#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001861790","owner_name":"Monahan Joseph","owner_display_name":"Monahan Joseph","owner_url":"/insider/0001861790","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.8823,"price_display":"15.88","price_state":"stated","total_value":79411.5,"total_display":"79,411.50","total_whole":"79,412","shares_owned_after":96386.0,"shares_owned_after_display":"96,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-16","scope":"insider"},{"id":6306118,"accession":"0001209191-22-054073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054073","line_url":"/filing/0001209191-22-054073#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001861790","owner_name":"Monahan Joseph","owner_display_name":"Monahan Joseph","owner_url":"/insider/0001861790","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.9815,"price_display":"15.98","price_state":"stated","total_value":79907.5,"total_display":"79,907.50","total_whole":"79,908","shares_owned_after":101386.0,"shares_owned_after_display":"101,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-17","filed_date":"2022-10-19","scope":"insider"},{"id":6546542,"accession":"0001209191-22-025032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025032","line_url":"/filing/0001209191-22-025032#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001861790","owner_name":"Monahan Joseph","owner_display_name":"Monahan Joseph","owner_url":"/insider/0001861790","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":16.2766,"price_display":"16.28","price_state":"stated","total_value":488298.0,"total_display":"488,298.00","total_whole":"488,298","shares_owned_after":106386.0,"shares_owned_after_display":"106,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-18","filed_date":"2022-04-20","scope":"insider"},{"id":6607651,"accession":"0001209191-22-018501","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-018501","line_url":"/filing/0001209191-22-018501#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001861790","owner_name":"Monahan Joseph","owner_display_name":"Monahan Joseph","owner_url":"/insider/0001861790","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27165.0,"shares_display":"27,165","price_per_share":15.7115,"price_display":"15.71","price_state":"stated","total_value":426802.8975,"total_display":"426,802.90","total_whole":"426,803","shares_owned_after":136386.0,"shares_owned_after_display":"136,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-10","filed_date":"2022-03-14","scope":"insider"},{"id":6388363,"accession":"0001209191-22-008860","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-008860","line_url":"/filing/0001209191-22-008860#line-1","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001861790","owner_name":"Monahan Joseph","owner_display_name":"Monahan Joseph","owner_url":"/insider/0001861790","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":383.0,"shares_display":"383","price_per_share":12.6818,"price_display":"12.68","price_state":"stated","total_value":4857.1294,"total_display":"4,857.13","total_whole":"4,857","shares_owned_after":87301.0,"shares_owned_after_display":"87,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-11","scope":"insider"},{"id":4227576,"accession":"0001209191-21-037478","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-037478","line_url":"/filing/0001209191-21-037478","is_derivative":false,"issuer_cik":"0001557746","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001557746","owner_cik":"0001861790","owner_name":"Monahan Joseph","owner_display_name":"Monahan Joseph","owner_url":"/insider/0001861790","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21790.0,"shares_display":"21,790","price_per_share":21.635456906837998,"price_display":"21.64","price_state":"stated","total_value":471436.606,"total_display":"471,436.61","total_whole":"471,437","shares_owned_after":88892.0,"shares_owned_after_display":"88,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-02","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001557746","name":"Aclaris Therapeutics, Inc.","url":"/issuer/0001557746","role":"Officer (Chief Scientific Officer)","n_filings":11,"first_seen":"2021-06-02","last_seen":"2023-10-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001861790","retrieved_at":"2026-08-25T19:03:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}